Literature DB >> 25074930

The merozoite surface protein 1 complex is a platform for binding to human erythrocytes by Plasmodium falciparum.

Clara S Lin1, Alessandro D Uboldi2, Danushka Marapana1, Peter E Czabotar1, Christian Epp3, Hermann Bujard4, Nicole L Taylor5, Matthew A Perugini5, Anthony N Hodder6, Alan F Cowman7.   

Abstract

Plasmodium falciparum is the causative agent of the most severe form of malaria in humans. The merozoite, an extracellular stage of the parasite lifecycle, invades erythrocytes in which they develop. The most abundant protein on the surface of merozoites is merozoite surface protein 1 (MSP1), which consists of four processed fragments. Studies indicate that MSP1 interacts with other peripheral merozoite surface proteins to form a large complex. Successful invasion of merozoites into host erythrocytes is dependent on this protein complex; however, the identity of all components and its function remain largely unknown. We have shown that the peripheral merozoite surface proteins MSPDBL1 and MSPDBL2 are part of the large MSP1 complex. Using surface plasmon resonance, we determined the binding affinities of MSPDBL1 and MSPDBL2 to MSP1 to be in the range of 2-4 × 10(-7) m. Both proteins bound to three of the four proteolytically cleaved fragments of MSP1 (p42, p38, and p83). In addition, MSPDBL1 and MSPDBL2, but not MSP1, bound directly to human erythrocytes. This demonstrates that the MSP1 complex acts as a platform for display of MSPDBL1 and MSPDBL2 on the merozoite surface for binding to receptors on the erythrocyte and invasion.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cell Invasion; Complex; Infection; Malaria; Merozoite; Parasite; Plasmodium; Protein Complex; falciparum

Mesh:

Substances:

Year:  2014        PMID: 25074930      PMCID: PMC4162169          DOI: 10.1074/jbc.M114.586495

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of antigenicity studies in humans.

Authors:  Corine G Demanga; Lena-Juliette Daher; Eric Prieur; Catherine Blanc; Jean-Louis Pérignon; Hasnaa Bouharoun-Tayoun; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

2.  Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes.

Authors:  Wai-Hong Tham; Christoph Q Schmidt; Richard E Hauhart; Mara Guariento; Patience B Tetteh-Quarcoo; Sash Lopaticki; John P Atkinson; Paul N Barlow; Alan F Cowman
Journal:  Blood       Date:  2011-06-17       Impact factor: 22.113

3.  Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites.

Authors:  Paul R Gilson; Brendan S Crabb
Journal:  Int J Parasitol       Date:  2008-10-11       Impact factor: 3.981

4.  Deletion of the Plasmodium falciparum merozoite surface protein 7 gene impairs parasite invasion of erythrocytes.

Authors:  Madhusudan Kadekoppala; Rebecca A O'Donnell; Munira Grainger; Brendan S Crabb; Anthony A Holder
Journal:  Eukaryot Cell       Date:  2008-09-26

5.  Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.

Authors:  E M Riley; S J Allen; J G Wheeler; M J Blackman; S Bennett; B Takacs; H J Schönfeld; A A Holder; B M Greenwood
Journal:  Parasite Immunol       Date:  1992-05       Impact factor: 2.280

6.  Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum.

Authors:  Daria Van Tyne; Daniel J Park; Stephen F Schaffner; Daniel E Neafsey; Elaine Angelino; Joseph F Cortese; Kayla G Barnes; David M Rosen; Amanda K Lukens; Rachel F Daniels; Danny A Milner; Charles A Johnson; Ilya Shlyakhter; Sharon R Grossman; Justin S Becker; Daniel Yamins; Elinor K Karlsson; Daouda Ndiaye; Ousmane Sarr; Souleymane Mboup; Christian Happi; Nicholas A Furlotte; Eleazar Eskin; Hyun Min Kang; Daniel L Hartl; Bruce W Birren; Roger C Wiegand; Eric S Lander; Dyann F Wirth; Sarah K Volkman; Pardis C Sabeti
Journal:  PLoS Genet       Date:  2011-04-21       Impact factor: 5.917

7.  Molecular identification of a malaria merozoite surface sheddase.

Authors:  Philippa K Harris; Sharon Yeoh; Anton R Dluzewski; Rebecca A O'Donnell; Chrislaine Withers-Martinez; Fiona Hackett; Lawrence H Bannister; Graham H Mitchell; Michael J Blackman
Journal:  PLoS Pathog       Date:  2005-11-25       Impact factor: 6.823

8.  Population genomic scan for candidate signatures of balancing selection to guide antigen characterization in malaria parasites.

Authors:  Alfred Amambua-Ngwa; Kevin K A Tetteh; Magnus Manske; Natalia Gomez-Escobar; Lindsay B Stewart; M Elizabeth Deerhake; Ian H Cheeseman; Christopher I Newbold; Anthony A Holder; Ellen Knuepfer; Omar Janha; Muminatou Jallow; Susana Campino; Bronwyn Macinnis; Dominic P Kwiatkowski; David J Conway
Journal:  PLoS Genet       Date:  2012-11-01       Impact factor: 5.917

9.  Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

Authors:  M J Blackman; T J Scott-Finnigan; S Shai; A A Holder
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

10.  Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunity.

Authors:  Kevin K A Tetteh; Faith H A Osier; Ali Salanti; Gathoni Kamuyu; Laura Drought; Marilyne Failly; Christophe Martin; Kevin Marsh; David J Conway
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

View more
  22 in total

1.  Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial.

Authors:  Antje Blank; Kristin Fürle; Anja Jäschke; Michael Lanzer; Walter E Haefeli; Hermann Bujard; Gerd Mikus; Monika Lehmann; Johannes Hüsing; Kirsten Heiss; Thomas Giese; Darrick Carter; Ernst Böhnlein
Journal:  NPJ Vaccines       Date:  2020-01-31       Impact factor: 7.344

2.  Merozoite Antigens of Plasmodium falciparum Elicit Strain-Transcending Opsonizing Immunity.

Authors:  Danika L Hill; Danny W Wilson; Natalia G Sampaio; Emily M Eriksson; Victoria Ryg-Cornejo; G L Abby Harrison; Alessandro D Uboldi; Leanne J Robinson; James G Beeson; Peter Siba; Alan F Cowman; Diana S Hansen; Ivo Mueller; Louis Schofield
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

3.  Merozoite surface protein 1 recognition of host glycophorin A mediates malaria parasite invasion of red blood cells.

Authors:  Michael R Baldwin; Xuerong Li; Toshihiko Hanada; Shih-Chun Liu; Athar H Chishti
Journal:  Blood       Date:  2015-03-16       Impact factor: 22.113

Review 4.  Host-parasite interactions that guide red blood cell invasion by malaria parasites.

Authors:  Aditya S Paul; Elizabeth S Egan; Manoj T Duraisingh
Journal:  Curr Opin Hematol       Date:  2015-05       Impact factor: 3.284

5.  Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.

Authors:  Arunaditya Deshmukh; Bishwanath Kumar Chourasia; Sonali Mehrotra; Ikhlaq Hussain Kana; Gourab Paul; Ashutosh Panda; Inderjeet Kaur; Susheel Kumar Singh; Sumit Rathore; Aparup Das; Priya Gupta; Md Kalamuddin; S K Gakhar; Asif Mohmmed; Michael Theisen; Pawan Malhotra
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

Review 6.  Red cell receptors as access points for malaria infection.

Authors:  Nichole D Salinas; Niraj H Tolia
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

7.  Multiple Plasmodium falciparum Merozoite Surface Protein 1 Complexes Mediate Merozoite Binding to Human Erythrocytes.

Authors:  Clara S Lin; Alessandro D Uboldi; Christian Epp; Hermann Bujard; Takafumi Tsuboi; Peter E Czabotar; Alan F Cowman
Journal:  J Biol Chem       Date:  2016-01-28       Impact factor: 5.157

8.  Screening and characterization of hypothetical proteins of Plasmodium falciparum as novel vaccine candidates in the fight against malaria using reverse vaccinology.

Authors:  Claire Aguttu; Brenda Apio Okech; Ambrose Mukisa; George William Lubega
Journal:  J Genet Eng Biotechnol       Date:  2021-07-16

9.  Na+ Influx Induced by New Antimalarials Causes Rapid Alterations in the Cholesterol Content and Morphology of Plasmodium falciparum.

Authors:  Sudipta Das; Suyash Bhatanagar; Joanne M Morrisey; Thomas M Daly; James M Burns; Isabelle Coppens; Akhil B Vaidya
Journal:  PLoS Pathog       Date:  2016-05-26       Impact factor: 6.823

Review 10.  The mechanics of malaria parasite invasion of the human erythrocyte - towards a reassessment of the host cell contribution.

Authors:  Marion Koch; Jake Baum
Journal:  Cell Microbiol       Date:  2016-01-11       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.